Thurston, Springer, Miller, Herd & Titak, Inc. Viatris Inc Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 1,301 shares of VTRS stock, worth $11,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,301
Previous 790
64.68%
Holding current value
$11,188
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$797 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$640 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$559 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$529 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...